[HTML][HTML] The effect of desensitization protocols on human splenic B-cell populations in vivo

EJ Ramos, HS Pollinger, MD Stegall, JM Gloor… - American Journal of …, 2007 - Elsevier
Rituximab, intravenous immunoglobulin (IVIG) and rabbit antithymocyte globulin (rATG) all
have been suggested to have an effect on antibody producing cells, however, supporting
data are lacking. To assess the impact of these agents on splenic B‐cell populations n vivo,
we retrospectively examined 25 spleens removed from patients treated with these agents as
part of desensitization protocols in either ABO incompatible or positive crossmatch living
donor kidney transplantation. These were compared to control (CTL) spleens removed for …